Zoetis Gets Green Light for Bird Flu Vaccine
This was the stock's third consecutive day of gains.
A perfect example of this combination today is animal healthcare specialist Zoetis (NYSE: ZTS). Whether helping our furry ...
3h
Greenwich Time on MSNGreenwich Academy's 2025 commencement speaker is the CEO of animal health company ZoetisGreenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
12d
Hosted on MSNZoetis Gears Up to Report Q4 Earnings: What's in the Cards?Zoetis, Inc. ZTS is expected to beat estimates when it reports its fourth-quarter 2024 results on Feb. 13, before the opening ...
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Shares of Zoetis ( ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results